In triple-negative breast cancer, high expression of XPO1 accelerates proliferation by exporting oncogene mRNAs such as MYC and ERBB2, inhibits mitochondrial release of Cyt c, and weakens apoptotic sensitivity (Zhao et al., 2021). The gene discussed is MYC; the disease is triple-negative breast carcinoma.